Alamodi Mohammed, Joueidi Faisal, Sayed Ahmed Gamal, Alsarari Abdulrahman, Alaswad Hani, Alhamdan Wejdan, Alendijani Yaser, Almufrij Sarah, Alkhenizan Abdullah
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia.
J Family Med Prim Care. 2024 Nov;13(11):5067-5071. doi: 10.4103/jfmpc.jfmpc_664_24. Epub 2024 Nov 18.
Bell's palsy (BP) is a cranial nerve disorder in which unilateral or bilateral paralysis of the facial nerve occurs. The study aims to study BP's characteristics, including its clinical manifestations, prognosis, and complications among adult patients aged 18 years and above.
A retrospective study of adult patients diagnosed with BP in a primary care setting] [January 2015 to December 2022].
The study included a total number of 92 patients with an incidence rate of 23 cases per 100,000 people. The mean age was 43.52 years. The most common symptoms reported were dropping of the mouth at 38.9%, loss of forehead muscle movement at 24.4%, loss of nasolabial fold at 22.2%, loss of facial expressions at 20%, and headache at 18.9%. Immunodeficiency affected 2.3% of the patients. The management of patients involved the use of steroids in 76.1% and the use of antiretroviral medications in 48.9%. Physiotherapy was used in 29.5%. The complete recovery rate during the first year was 90.8%. The rate of complete recovery within two years was 96.9%.
The incidence of BP in the region seems to be similar to the incidence rate reported elsewhere in the world. The use of antiviral therapy seems to be high despite the controversy around the use of antivirals in the management of BP. The majority of patients with BP recover within the first year.
贝尔麻痹(BP)是一种颅神经疾病,可出现单侧或双侧面神经麻痹。本研究旨在研究18岁及以上成年患者贝尔麻痹的特征,包括其临床表现、预后和并发症。
对2015年1月至2022年12月在基层医疗环境中诊断为贝尔麻痹的成年患者进行回顾性研究。
该研究共纳入92例患者,发病率为每10万人23例。平均年龄为43.52岁。报告的最常见症状为口角下垂(38.9%)、额肌运动丧失(24.4%)、鼻唇沟消失(22.2%)、面部表情丧失(20%)和头痛(18.9%)。免疫缺陷影响了2.3%的患者。患者的治疗包括76.1%使用类固醇,48.9%使用抗逆转录病毒药物。29.5%使用物理治疗。第一年的完全恢复率为90.8%。两年内的完全恢复率为96.9%。
该地区贝尔麻痹的发病率似乎与世界其他地方报告的发病率相似。尽管在贝尔麻痹治疗中使用抗病毒药物存在争议,但抗病毒治疗的使用率似乎很高。大多数贝尔麻痹患者在第一年内康复。